DelveInsight Business Research, LLP: Adrenocortical Carcinoma Market to Exhibit Growth at a CAGR of 11.1% by 2034
According to DelveInsight's' estimates, the adrenocortical carcinoma market in 7MM is expected to show positive growth, during the forecast period (2024-2034), mainly attributed to the anticipated
United Kingdom United States Neurocrine Biosciences Prnewswire Delveinsight Bristol Myers Squibb Shruti Thakur
Source: finanznachrichten.de